Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.

Johansson G, Mahller YY, Collins MH, Kim MO, Nobukuni T, Perentesis J, Cripe TP, Lane HA, Kozma SC, Thomas G, Ratner N.

Mol Cancer Ther. 2008 May;7(5):1237-45. doi: 10.1158/1535-7163.MCT-07-2335.

2.
3.

Malignant peripheral nerve sheath tumour (MPNST): the clinical implications of cellular signalling pathways.

Katz D, Lazar A, Lev D.

Expert Rev Mol Med. 2009 Oct 19;11:e30. doi: 10.1017/S1462399409001227. Review.

PMID:
19835664
4.

Everolimus.

Hasskarl J.

Recent Results Cancer Res. 2014;201:373-92. doi: 10.1007/978-3-642-54490-3_23. Review.

PMID:
24756805
5.

Malignant peripheral nerve sheath tumors.

Farid M, Demicco EG, Garcia R, Ahn L, Merola PR, Cioffi A, Maki RG.

Oncologist. 2014 Feb;19(2):193-201. doi: 10.1634/theoncologist.2013-0328. Epub 2014 Jan 27. Review.

6.

Malignant Peripheral Nerve Sheath Tumors State of the Science: Leveraging Clinical and Biological Insights into Effective Therapies.

Kim A, Stewart DR, Reilly KM, Viskochil D, Miettinen MM, Widemann BC.

Sarcoma. 2017;2017:7429697. doi: 10.1155/2017/7429697. Epub 2017 May 16. Review.

Supplemental Content

Support Center